BAT Says Potential COVID-19 Vaccine Using Tobacco Leaves Ready For Human Trials
World’s No.2 cigarette company British American Tobacco said it was ready to test its potential COVID-19 vaccine using proteins from tobacco leaves on humans, after it generated a positive immune response in pre-clinical trials.
The maker of Lucky Strike cigarette said once it gets approval from the US Food and Drug administration (FDA) for the vaccine, it would progress to Phase 1 trials or testing on humans.
The company raised eyebrows in April when it said it was developing a COVID-19 vaccine from tobacco leaves and could produce 1 million to 3 million doses per week if it got the support of government agencies and the right manufacturers.
ESM
Related news
France kicks off bird flu vaccination despite trade backlash risk
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >The durable and transparent packaging is the winner – results on the soup paste dry pasta Product sample
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >Magazine: László Krisán: “Everyone has their share of responsibility in crisis management”
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >Related news
K&H was named the Green Large Company of the Year
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >Retail sales in the Czech Republic increased by 2.5 percent in July
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >LG’s new washing machines come with a microplastic filter
🎧 Hallgasd a cikket: Lejátszás Szünet Folytatás Leállítás Nyelv: Auto…
Read more >